Company CVAbout Norris Medicines Ltd 
Norris Medicines Ltd
Micro Cap
Pharmaceuticals & Drugs
Norris Medicines Limited was established in September, 1990 as a small scale unit at GIDC Estate, Ankleshwar to manufacture non sterile dosage e.g. tablets, capsules, Liquid Orals, Copical ointments. The Company was subsequently converted into Public Limited Company on March 7, 1992. The unit expanded to manufacture Sterile dosage in form of Ampoules & Vials. The Company got into the business in the year 1990. Commercial production of the formulation unit commenced in Nov.'91.
Company Coordinates
Company Details
Plot No 801/P & 802, GIDC Industrial Estate Ankleshwar Gujarat : 393002
Registrar Details
Purva Shareregistry (India) Pvt Ltd , Gala No 9, Shiv Shakti, Industrial Estate,Sitaram Mill Comp., J R Boricha Marg, Lower Parel [E], Mumbai
Capital StructureCapital Structure
Present Equity Capital
INR 10.00 Cr
Number of Shares
1 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
10-Mar-2014
1
10.00
7060700
10
Allotment of Equity Shares To Promoter & Others
10-Mar-2014
1
10.00
7060700
10
Allotment of Equity Shares To Promoter & Others
22-Aug-2013
98
2.94
0
3
Capital Reduction
22-Aug-2013
29.4
2.94
-6860000
10
Consolidation of Shares
22-Aug-2013
98
2.94
0
3
Capital Reduction
22-Aug-2013
29.4
2.94
-6860000
10
Consolidation of Shares
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Non Institution
Pledged Promoter Holdings
None
Mutual Funds
Held by 2 Schemes (0.01%)
FIIs
Held by 0 FIIs
Promoter with highest holding
Vimal D Shah (23.6%)
Highest Public shareholder
Fab Metals Private Limited (41.99%)
Individual Investors Holdings
20.73%
Board of Directors
Management
Designation
Remuneration
Vimal D Shah
Managing Director
6.0 lacs
Hiten Parikh
Independent Director
0
S A M Azmathullah
Independent Director
0
Susmita Mahapatra
Independent Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
Trading Finish (TPO)
0.15924
0%
Trading Finish (TPO)
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Excise
-0.08
-0.47%
Excise
Excise
Stock DNARevenue and Profits:
Net Sales:
1 Cr
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
Pharmaceuticals & Drugs
INR 16 Cr (Micro Cap)
NA (Loss Making)
33
0.00%
-1.50
5.85%
-1.12
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
